These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 28196852)
1. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
2. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264 [TBL] [Abstract][Full Text] [Related]
3. The INPP4B paradox: Like PTEN, but different. Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856 [TBL] [Abstract][Full Text] [Related]
4. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling. Li H; Marshall AJ Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022 [TBL] [Abstract][Full Text] [Related]
7. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN. Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321 [TBL] [Abstract][Full Text] [Related]
8. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Sharrard RM; Maitland NJ Cell Signal; 2007 Jan; 19(1):129-38. PubMed ID: 16842970 [TBL] [Abstract][Full Text] [Related]
9. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities. Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612 [TBL] [Abstract][Full Text] [Related]
10. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919 [TBL] [Abstract][Full Text] [Related]
11. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222 [TBL] [Abstract][Full Text] [Related]
12. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer. Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269 [TBL] [Abstract][Full Text] [Related]
13. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice. Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098 [TBL] [Abstract][Full Text] [Related]
14. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor. Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298 [TBL] [Abstract][Full Text] [Related]
15. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells. Sun Y; Ding H; Liu X; Li X; Li L Tumour Biol; 2014 May; 35(5):4469-77. PubMed ID: 24420152 [TBL] [Abstract][Full Text] [Related]
16. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer. Rodgers SJ; Ooms LM; Oorschot VMJ; Schittenhelm RB; Nguyen EV; Hamila SA; Rynkiewicz N; Gurung R; Eramo MJ; Sriratana A; Fedele CG; Caramia F; Loi S; Kerr G; Abud HE; Ramm G; Papa A; Ellisdon AM; Daly RJ; McLean CA; Mitchell CA Nat Commun; 2021 May; 12(1):3140. PubMed ID: 34035258 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells. Chai C; Wu H; Wang B; Eisenstat DD; Leng RP Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991 [TBL] [Abstract][Full Text] [Related]
18. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244 [TBL] [Abstract][Full Text] [Related]
19. Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung. Stjernström A; Karlsson C; Fernandez OJ; Söderkvist P; Karlsson MG; Thunell LK Cancer Med; 2014 Apr; 3(2):337-48. PubMed ID: 24500884 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3. Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]